DIA Biosimilars 2013

Omnicare

Omnicare names McGuan senior VP

Wednesday, August 10, 2011 11:17 AM

Omnicare has named Kathleen McGuan its senior vice president and chief compliance officer. McGuan will oversee and lead Omnicare's corporate compliance function.  In this role, she will be a key contributor as the company continues to reinforce its commitment on compliance. McGuan was formerly Omnicare's interim chief compliance officer. 

More... »

Cenduit: Now with Patient Reminders

PRA on the block, too?

Monday, August 8, 2011 08:02 AM

There was much hoopla made about PPD possibly being for sale after the Wall Street Journal published a story saying as much in mid-July. But what about its smaller competitor, PRA International?

More... »

CRF Health – eCOA Forum

Omnicare names EVP, human resources

Tuesday, August 2, 2011 11:06 AM

Omnicare has named Priscilla Stewart-Jones executive vice president, human resources. She will oversee and lead the human resource function across the company, playing a critical role in the continuing efforts to reshape Omnicare's corporate culture. She will join the company effective September 5, 2011.

More... »

Omnicare re-brands as Theorem Clinical Research

Thursday, June 16, 2011 10:29 AM

CRO Omnicare Clinical Research, based in King of Prussia, Penn., has re-branded the company under the name Theorem Clinical Research. The brand launch marks the final step in the CRO's separation from its former parent company in a deal that was finalized this spring.

More... »

Nautic purchase of Omnicare Clinical Research part of recent acquisition trend of mid-sized CROs

Thursday, May 5, 2011 01:22 PM

Omnicare Clinical Research, which had been part of publicly traded long-term care pharmacy company Omnicare Inc. since the late 1990s, was acquired by private equity firm Nautic Partners last week, making it one of several mid-sized CROs to be acquired in the last year.

More... »

Nautic Partners acquires CRO Omnicare

Thursday, April 28, 2011 08:01 AM

Investment firm Nautic Partners has purchased the CRO Omnicare Clinical Research (CR) from its parent company Omnicare Inc., a publicly traded company that focuses primarily on providing pharmaceuticals and ancillary services to long-term care institutions.

More... »

Omnicare Clinical Research Opens Seoul Office

Thursday, November 5, 2009 08:33 AM

Pennsylvania-based Omnicare Clinical Research, a global contract research organization (CRO), has opened an office in Seoul, South Korea.

More... »

Pusey Appointed President, CEO of Omnicare Clinical Research

Tuesday, October 20, 2009 08:01 AM

Omnicare appointed James Pusey as president and CEO of Omnicare Clinical Research. In his new position, Pusey will be responsible for Omnicare’s contract research organization (CRO) operations worldwide.

More... »

PharmaNet Launches Clinical Trial Staffing Service

Thursday, March 12, 2009 09:00 AM

Despite a pending acquisition by private equity firm JLL Partners, contract research organization (CRO) PharmaNet continues to expand its service offerings and locations.

More... »

Omnicare's CRO Division Holds Steady

Friday, February 27, 2009 09:00 AM

Omnicare reported its fourth quarter and year-end 2008 financial results, including the results for Omnicare’s subsidiary, contract research organization Omnicare Clinical Research.

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs